CIK 0001314052
- Large accelerated filer
- Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 980608404
- Phone
- +1 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Thomas Steffen Director | Exercise or conversion | +50,000 | $1.76 | $88K | 55,000 |
| 2025-06-05 | Thomas Steffen Director | Shares withheld for taxes | −11,349 | $7.75 | $88K | 43,651 |
| 2025-06-05 | Thomas Steffen Director | Exercise or conversion · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2025-03-31 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-15 | Thomas Steffen Director | Purchase | +5,000 | $4.52 | $23K | 5,000 |
| 2024-02-20 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-31 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-27 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-08-02 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-12-30 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-01-06 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-10-01 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2016-09-22 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 1 of 1 · 13 trades